Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Pain
|
June 14, 2024
A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular pain
Alan Miller, Kenneth D Candido, Nebojsa Nick Knezevic, et al.
Nature Medicine
|
April 14, 2026
Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial
Devalingam Mahalingam, Rachna T Shroff, Benedito A Carneiro, et al.
Plos Medicine
|
September 21, 2020
Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study
Edward C Smith, Laurie S Conklin, Eric P Hoffman, et al.
Neurology
|
August 28, 2019
Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function
Eric P Hoffman, Benjamin D Schwartz, Laurel J Mengle-Gaw, et al.
Pharmacological Research
|
September 17, 2018
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug
Laurie S Conklin, Jesse M Damsker, Eric P Hoffman, et al.
JAMA Neurology
|
August 29, 2022
Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial
Michela Guglieri, Paula R Clemens, Seth J Perlman, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Pain
|
June 14, 2024
A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular pain
Alan Miller, Kenneth D Candido, Nebojsa Nick Knezevic, et al.
Nature Medicine
|
April 14, 2026
Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial
Devalingam Mahalingam, Rachna T Shroff, Benedito A Carneiro, et al.
Plos Medicine
|
September 21, 2020
Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study
Edward C Smith, Laurie S Conklin, Eric P Hoffman, et al.
Neurology
|
August 28, 2019
Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function
Eric P Hoffman, Benjamin D Schwartz, Laurel J Mengle-Gaw, et al.
Pharmacological Research
|
September 17, 2018
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug
Laurie S Conklin, Jesse M Damsker, Eric P Hoffman, et al.
JAMA Neurology
|
August 29, 2022
Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial
Michela Guglieri, Paula R Clemens, Seth J Perlman, et al.
Page
of 3